Molecular testing of lung cancer. EGFR, ALK, ROS1, BRAF, KRAS, MET, RET, PIK3CA testing.

Lung cancer
EGFR
ALK
ROS1
KRAS
BRAF
PIK3CA
RET
MET (amplification)
MET (exon 14 skipping)

Five cases for round 1, Four cases for round 2

Any

Formalin fixed paraffin embedded sections supplied as
1) rolled sections,
2) slide mounted sections
or 3) rolled sections plus one slide mounted section for H&E staining.
Please indicate your sample choice when enrolling.

Any molecular testing methods.

Submit a clinical report to include:
• Genotyping of results
• Interpretation of the result
• Clerical accuracy
Performance criteria are applied.

All laboratories worldwide

English ONLY

Yes

Sample dispatch	April 2020 <br>October 2020
Testing period	6 weeks
Assessment results	August 2020 <br>February 2021
Final Summary report	October 2020 <br>April 2021

Two distributions per year

£800.00

2020LALL1